Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial.
dc.contributor.author | Olldashi, F. | |
dc.contributor.author | Kerçi, M. | |
dc.contributor.author | Zhurda, T. | |
dc.contributor.author | Ruçi, K. | |
dc.contributor.author | Naaeder, J.C.B. | |
dc.contributor.author | Traverso, M.S. | |
dc.contributor.author | Chengo, C. | |
dc.date.accessioned | 2013-06-21T19:30:03Z | |
dc.date.accessioned | 2017-10-19T13:08:10Z | |
dc.date.available | 2013-06-21T19:30:03Z | |
dc.date.available | 2017-10-19T13:08:10Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Olldashi, F., Kerçi, M., Zhurda, T., Ruçi, K., Naaeder, S. B., Traverso, M. S., . . . Chengo, C. (2010). Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. The Lancet, 376(9734), 23-32. | en_US |
dc.identifier.uri | http://197.255.68.203/handle/123456789/3941 | |
dc.language.iso | en | en_US |
dc.title | Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. | en_US |
dc.type | Article | en_US |